Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 59 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Papaefthymiou, Apostolis [Clear All Filters]
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents..
J Crohns Colitis.
(2021). Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders..
Metabolism. 154736.
(2021). A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension..
Liver Int.
(2021). Role of autophagy in gastric carcinogenesis..
World J Gastrointest Oncol. 13(10), 1244-1262.
(2021). The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis..
Neurochem Int. 144, 104938.
(2021). Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients..
J Clin Med. 9(4),
(2020). Alzheimer's disease and gastrointestinal microbiota; impact of infection involvement..
Int J Neurosci. 1-13.
(2020). Association between Active Infection and Glaucoma: A Systematic Review and Meta-Analysis..
Microorganisms. 8(6),
(2020). Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'..
Carcinogenesis.
(2020). Helicobacter pylori infection as a potential risk factor for multiple sclerosis..
Med Hypotheses. 143, 110135.
(2020). Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?.
Obes Surg.
(2020). Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited..
J Gastrointestin Liver Dis. 29(2), 270-271.
(2020).
(2020). Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease..
Aliment Pharmacol Ther. 51(2), 313-314.
(2020). Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma..
Aliment Pharmacol Ther. 51(11), 1215-1216.
(2020). National consensus on infection: the next-day challenge..
Ann Gastroenterol. 33(3), 324-325.
(2020). Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap..
J Clin Gastroenterol. 54(2), 200-201.
(2020). Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis..
Dig Liver Dis. 52(1), 121-123.
(2020). Response to letter to the editor of Carcinogenesis by Li et al., 2020..
Carcinogenesis. 41(4), 539-540.
(2020). Rodent models of obesity..
Minerva Endocrinol. 45(3), 243-263.
(2020). Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents..
Expert Opin Pharmacother. 21(3), 247-251.
(2020). Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial..
Medicina (Kaunas). 56(7),
(2020). Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection..
Int J Clin Pract. e13737.
(2020). Comments to the Editor concerning the paper entitled "The microbiome and ophthalmic disease" by Baim et al..
Exp Biol Med (Maywood). 244(6), 430-432.
(2019). Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection..
Cell Mol Life Sci. 76(13), 2487-2488.
(2019).